Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
29.77
+0.66 (2.25%)
Apr 29, 2026, 9:41 AM EDT - Market open
Sensei Biotherapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 8.67 | 9.99 | 13.01 | 17.8 | 7.16 | Upgrade
|
| Short-Term Investments | 12.52 | 31.34 | 52.75 | 89.32 | 140.46 | Upgrade
|
| Cash & Short-Term Investments | 21.18 | 41.34 | 65.76 | 107.12 | 147.62 | Upgrade
|
| Cash Growth | -48.75% | -37.14% | -38.61% | -27.44% | 789.50% | Upgrade
|
| Prepaid Expenses | 0.23 | 0.47 | 1.17 | 1.13 | 0.55 | Upgrade
|
| Other Current Assets | 0.09 | 0.12 | 0.33 | 0.34 | 0.37 | Upgrade
|
| Total Current Assets | 21.51 | 41.93 | 67.25 | 108.59 | 148.54 | Upgrade
|
| Property, Plant & Equipment | 1.38 | 3.38 | 7.04 | 9.72 | 4.64 | Upgrade
|
| Other Long-Term Assets | 0.02 | 0.05 | 0.09 | 0.06 | 0.04 | Upgrade
|
| Total Assets | 22.9 | 45.36 | 74.37 | 118.38 | 153.23 | Upgrade
|
| Accounts Payable | 0.69 | 0.24 | 0.57 | 4.47 | 2.46 | Upgrade
|
| Accrued Expenses | 2.04 | 2.73 | 2.41 | 2.46 | 1.75 | Upgrade
|
| Current Portion of Leases | 1.45 | 2.32 | 2.44 | 2.13 | 0.68 | Upgrade
|
| Other Current Liabilities | 0.08 | 0.16 | 0.22 | - | - | Upgrade
|
| Total Current Liabilities | 4.25 | 5.45 | 5.64 | 9.07 | 4.89 | Upgrade
|
| Long-Term Leases | 0.06 | 1.53 | 3.77 | 5.9 | 1.67 | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.07 | - | 0.15 | Upgrade
|
| Total Liabilities | 4.31 | 6.98 | 9.48 | 14.97 | 6.71 | Upgrade
|
| Common Stock | - | - | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 301.73 | 300.45 | 297 | 302.2 | 296.05 | Upgrade
|
| Retained Earnings | -283.14 | -262.05 | -231.9 | -197.79 | -149.21 | Upgrade
|
| Comprehensive Income & Other | 0 | -0.01 | -0.21 | -1 | -0.33 | Upgrade
|
| Total Common Equity | 18.59 | 38.39 | 64.9 | 103.41 | 146.51 | Upgrade
|
| Shareholders' Equity | 18.59 | 38.39 | 64.9 | 103.41 | 146.51 | Upgrade
|
| Total Liabilities & Equity | 22.9 | 45.36 | 74.37 | 118.38 | 153.23 | Upgrade
|
| Total Debt | 1.51 | 3.85 | 6.21 | 8.03 | 2.35 | Upgrade
|
| Net Cash (Debt) | 19.68 | 37.49 | 59.55 | 99.08 | 145.27 | Upgrade
|
| Net Cash Growth | -47.52% | -37.04% | -39.90% | -31.79% | 813.00% | Upgrade
|
| Net Cash Per Share | 15.61 | 29.85 | 42.61 | 64.54 | 104.85 | Upgrade
|
| Filing Date Shares Outstanding | 1.34 | 1.26 | 1.25 | 1.55 | 1.53 | Upgrade
|
| Total Common Shares Outstanding | 1.26 | 1.26 | 1.25 | 1.54 | 1.53 | Upgrade
|
| Working Capital | 17.26 | 36.48 | 61.61 | 99.52 | 143.65 | Upgrade
|
| Book Value Per Share | 14.74 | 30.49 | 51.85 | 67.23 | 95.73 | Upgrade
|
| Tangible Book Value | 18.59 | 38.39 | 64.9 | 103.41 | 146.51 | Upgrade
|
| Tangible Book Value Per Share | 14.74 | 30.49 | 51.85 | 67.23 | 95.73 | Upgrade
|
| Machinery | 0.37 | 1.66 | 2.64 | 3.24 | 5.58 | Upgrade
|
| Leasehold Improvements | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.